Adam Aukland-Peck

Associate
New York
Tel: +1 212 909 6703
Overview
Adam Aukland-Peck is an associate in the Litigation Department. Mr. Aukland-Peck joined Debevoise in 2017. In 2020 he clerked for the Hon. Mary Kay Vyskocil ... Read Full Biography

Publications

  • Increased FCA Enforcement Targeting PE Firms Expected in 2024
    11 March 2024
    Helen V. Cantwell
    ,
    Courtney M. Dankworth
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Winston M. Paes
    ,
    Shannon Rose Selden
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Kaitlyn McGill
  • Court Finds That Delaware Law Does Not Preclude Derivative Standing in Bankruptcy but Reaffirms Validity of Exculpation Provisions
    6 March 2024
    M. Natasha Labovitz
    ,
    Shannon Rose Selden
    ,
    Erica S. Weisgerber
    ,
    Zachary H. Saltzman
    ,
    Elie J. Worenklein
    ,
    Adam Aukland-Peck
    ,
    Kimberly Anker
  • Private Equity Report: 2024 Outlook
    February 2024
    Christopher Anthony
    ,
    Katherine Ashton
    ,
    Andrew L. Bab
    ,
    Paul S. Bird
    ,
    Dominic Blaxill
    ,
    Ezra Borut
    ,
    Geoffrey P. Burgess
    ,
    Andrew J. Ceresney
    ,
    Charu A. Chandrasekhar
    ,
    Jennifer L. Chu
    ,
    Luke P. Eldridge
    ,
    Luke Dembosky
    ,
    E. Drew Dutton
    ,
    Jane Engelhardt
    ,
    Avi Gesser
    ,
    Andrew J. Gershon
    ,
    Nia I. Goodman
    ,
    David Grosgold
    ,
    Jyotin Hamid
    ,
    Ted Hassi
    ,
    Morgan J. Hayes
    ,
    Peter J. Irwin
    ,
    Eric T. Juergens
    ,
    Robert B. Kaplan
    ,
    M. Natasha Labovitz
    ,
    Jonathan F. Lewis
    ,
    Sidney P. Levinson
    ,
    Andrew M. Levine
    ,
    Erez Liebermann
    ,
    Timothy McIver
    ,
    Maura Kathleen Monaghan
    ,
    Edwin Northover
    ,
    Brett M. Novick
    ,
    Marc Ponchione
    ,
    Ryan T. Rafferty
    ,
    Natalie L. Reid
    ,
    Julie M. Riewe
    ,
    Kevin Rinker
    ,
    Samantha J. Rowe
    ,
    Paul D. Rubin
    ,
    Michael Schaper
    ,
    Kevin M. Schmidt
    ,
    Scott B. Selinger
    ,
    Aly Love Simons
    ,
    Thomas Smith
    ,
    Kristin A. Snyder
    ,
    Steven J. Slutzky
    ,
    Ramya S. Tiller
    ,
    Patricia Volhard
    ,
    Erica S. Weisgerber
    ,
    Kyra K. Bromley
    ,
    Alison E. Buckley-Serfass
    ,
    Jennifer R. Cestaro
    ,
    Stuart Hammer
    ,
    Jin-Hyuk Jang
    ,
    Wen-Wei Lai
    ,
    Michael P. McGuigan
    ,
    Sheena Paul
    ,
    Melissa Runsten
    ,
    Tricia Bozyk Sherno
    ,
    Ulysses Smith
    ,
    Sergio Torres
    ,
    Elie J. Worenklein
    ,
    Adam Aukland-Peck
    ,
    Josephine Chen
    ,
    Perpétua B. Chéry
    ,
    Paul Eastham
    ,
    Isabelle Glimcher
    ,
    Yiran Ji
    ,
    Maryam Kanna
    ,
    Leah Martin
    ,
    Sophie Michalski
    ,
    Diana Moise
    ,
    David J. Swiedler
    ,
    Perri M. Weinstein
    ,
    Nathan R. Hogan
  • Chevron Under Fire: What Healthcare and Life Sciences Investors Should Know
    19 January 2024
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Melissa Runsten
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Zoe Jacoby
    ,
    Adriana Kranjac
    ,
    Kaitlyn McGill
  • Top 10 Healthcare and Life Sciences Issues to Watch in 2024
    4 January 2024
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Ted Hassi
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Michael Schaper
    ,
    Erica S. Weisgerber
    ,
    Kim T. Le
    ,
    Melissa Runsten
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Ilya Balabanovsky
    ,
    Michael L. Cederblom
    ,
    Margaret Howard
    ,
    Chaim Lapp
    ,
    Hannah R. Levine
    ,
    Zoe Jacoby
    ,
    Kaitlyn McGill
  • 2023 Private Equity Midyear Outlook
    27 July 2023
    Christopher Anthony
    ,
    Katherine Ashton
    ,
    Dominic Blaxill
    ,
    Joe Binder
    ,
    Ezra Borut
    ,
    Geoffrey P. Burgess
    ,
    Andrew J. Ceresney
    ,
    Jeffrey P. Cunard
    ,
    E. Drew Dutton
    ,
    Jane Engelhardt
    ,
    Andrew Ford
    ,
    Andrew J. Gershon
    ,
    Mark P. Goodman
    ,
    Jyotin Hamid
    ,
    Ted Hassi
    ,
    Morgan J. Hayes
    ,
    Emily F. Huang
    ,
    Peter J. Irwin
    ,
    Eric T. Juergens
    ,
    Robert B. Kaplan
    ,
    Rafael Kariyev
    ,
    Meir D. Katz
    ,
    M. Natasha Labovitz
    ,
    Maurizio Levi-Minzi
    ,
    Andrew M. Levine
    ,
    Sidney P. Levinson
    ,
    Jonathan F. Lewis
    ,
    Timothy McIver
    ,
    Franklin L. Mitchell
    ,
    Maura Kathleen Monaghan
    ,
    Edwin Northover
    ,
    Brett M. Novick
    ,
    Marc Ponchione
    ,
    Julie M. Riewe
    ,
    Shannon Rose Selden
    ,
    Steven J. Slutzky
    ,
    Thomas Smith
    ,
    Kristin A. Snyder
    ,
    J. Michael Snypes, Jr.
    ,
    Patrick Taylor
    ,
    Ramya S. Tiller
    ,
    Patricia Volhard
    ,
    Richard Ward
    ,
    Erica S. Weisgerber
    ,
    Alison E. Buckley-Serfass
    ,
    Brett Adam Bush
    ,
    Zhiyan Cao
    ,
    Robert T. Dura
    ,
    Stuart Hammer
    ,
    Megan McGuiggan
    ,
    Sheena Paul
    ,
    Tricia Bozyk Sherno
    ,
    Ulysses Smith
    ,
    Jacob W. Stahl
    ,
    Sergio Torres
    ,
    Jennifer Wheater
    ,
    Elie J. Worenklein
    ,
    Adam Aukland-Peck
    ,
    Colleen B. Bernaiche
    ,
    Charles Cartiglia
    ,
    Paul Eastham
    ,
    Jay E. Evans
    ,
    Sara Ewad
    ,
    Christopher Gossage
    ,
    Camila Isern
    ,
    Yiran Ji
    ,
    Maryam Kanna
    ,
    Rekha Korlipara
    ,
    Adriana Kranjac
    ,
    Samuel D. Krawiecz
    ,
    Harshil Mehta
    ,
    Gianni Pizzitola
    ,
    Stanley G. Seckler
    ,
    Sheng Shao
    ,
    Massy Vainshtein
    ,
    Kimberly Anker
  • Sackett v. EPA: Supreme Court Clarifies Clean Water Act Scope but Creates Uncertainty for Companies and Investors
    7 July 2023
    Shannon Rose Selden
    ,
    Adam Aukland-Peck
    ,
    Ulysses Smith
  • Legal Dispute Surrounding Abortion Pill Has Significant Implications for Broader Healthcare Industry
    9 May 2023
    Andrew L. Bab
    ,
    Maura Kathleen Monaghan
    ,
    Paul D. Rubin
    ,
    Shannon Rose Selden
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Prakriti Luthra
    ,
    Melissa Runsten
  • Reuters: The new frontier of fraud, waste and abuse: COVID-related misconduct enforcement trends
    27 March 2023
    Reuters
    Maura Kathleen Monaghan
    ,
    Winston M. Paes
    ,
    Adam Aukland-Peck
    ,
    Hannah R. Levine
  • Top 15 Healthcare and Life Sciences Issues to Watch in 2023
    9 January 2023
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Michael Schaper
    ,
    Erica S. Weisgerber
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Elie J. Worenklein
    ,
    Samuel J. Allaman
    ,
    Adam Aukland-Peck
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
    ,
    Adam C. Saunders
    ,
    Adrian St. Francis
    ,
    Emily G. Dennan
    ,
    Michael L. Cederblom
    ,
    Micah A. Rubin
  • Recent SCOTUS Decisions Impacting Healthcare
    3 August 2022
    Andrew L. Bab
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
  • Texas Federal Judge Sides with Providers in “No Surprises Act” Ruling
    1 March 2022
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Adriana Kranjac
    ,
    Hannah R. Levine
    ,
    Melissa Runsten
  • 2021/2022 Private Equity Year-End Review and Outlook
    January 2022
    Jonathan Adler
    ,
    Catherine Amirfar
    ,
    Christopher Anthony
    ,
    Katherine Ashton
    ,
    Andrew L. Bab
    ,
    Geoffrey P. Burgess
    ,
    Ezra Borut
    ,
    Andrew J. Ceresney
    ,
    Jennifer L. Chu
    ,
    Jeffrey P. Cunard
    ,
    Alexander R. Cochran
    ,
    E. Drew Dutton
    ,
    Jane Engelhardt
    ,
    Morgan J. Hayes
    ,
    Eric T. Juergens
    ,
    Maurizio Levi-Minzi
    ,
    Nicholas P. Pellicani
    ,
    Ryan T. Rafferty
    ,
    Julie M. Riewe
    ,
    Scott B. Selinger
    ,
    Marc Ponchione
    ,
    Thomas Smith
    ,
    Ramya S. Tiller
    ,
    Patricia Volhard
    ,
    Richard Ward
    ,
    Alisa A. Waxman
    ,
    Marshal L. Bozzo
    ,
    Christopher Dortschy
    ,
    Andrew J. Gershon
    ,
    Emily F. Huang
    ,
    Jennifer Wheater
    ,
    Dominic Blaxill
    ,
    Charles Cartiglia
    ,
    Robert T. Dura
    ,
    Matthew J. Sacco
    ,
    Sheng Shao
    ,
    Sergio Torres
    ,
    Charlotte A. Walkovik
    ,
    Paul Eastham
    ,
    Christopher Gossage
    ,
    Robert B. Kaplan
    ,
    Sheena Paul
    ,
    John Young
    ,
    Jin-Hyuk Jang
    ,
    Lukas Ott
    ,
    Andrew M. Levine
    ,
    Stuart Hammer
    ,
    Ulysses Smith
    ,
    Luke Dembosky
    ,
    Avi Gesser
    ,
    Michael R. Roberts
    ,
    Peter J. Irwin
    ,
    Ina C. Popova
    ,
    Samantha J. Rowe
    ,
    M. Natasha Labovitz
    ,
    Sidney P. Levinson
    ,
    Paul D. Rubin
    ,
    Eric Dinallo
    ,
    Marilyn A. Lion
    ,
    Jacob W. Stahl
    ,
    Nicholas F. Potter
    ,
    Kim T. Le
    ,
    Adam Aukland-Peck
    ,
    Melissa Runsten
    ,
    Matthew Mrozek
    ,
    Michael C. Godbe
    ,
    Christel Y. Tham
    ,
    Lisa Wang Lachowicz
    ,
    Yiran Ji
  • Law360: Medicare Advantage Plans Must Beware DOJ Scrutiny
    5 January 2022
    Law360
    Winston M. Paes
    ,
    Kristin D. Kiehn
    ,
    Adam Aukland-Peck
  • 2021 Private Equity Midyear Review and Outlook
    22 July 2021
    Jonathan Adler
    ,
    Christopher Anthony
    ,
    Katherine Ashton
    ,
    Andrew L. Bab
    ,
    Megan K. Bannigan
    ,
    Sally Bergmann Hardesty
    ,
    David H. Bernstein
    ,
    Paul S. Bird
    ,
    Ezra Borut
    ,
    Geoffrey P. Burgess
    ,
    Jennifer L. Chu
    ,
    Matthew Dickman
    ,
    Christopher Dortschy
    ,
    E. Drew Dutton
    ,
    Jane Engelhardt
    ,
    Peter A. Furci
    ,
    Avi Gesser
    ,
    Jyotin Hamid
    ,
    Morgan J. Hayes
    ,
    Peter J. Irwin
    ,
    Meir D. Katz
    ,
    Rafael Kariyev
    ,
    M. Natasha Labovitz
    ,
    Maurizio Levi-Minzi
    ,
    Andrew M. Levine
    ,
    Sidney P. Levinson
    ,
    Jonathan F. Lewis
    ,
    Marc Ponchione
    ,
    Ryan T. Rafferty
    ,
    Paul D. Rubin
    ,
    Zachary H. Saltzman
    ,
    Kevin M. Schmidt
    ,
    Shannon Rose Selden
    ,
    Scott B. Selinger
    ,
    Steven J. Slutzky
    ,
    Ramya S. Tiller
    ,
    Richard Ward
    ,
    Alisa A. Waxman
    ,
    Patricia Volhard
    ,
    Franci J. Blassberg
    ,
    Jeffrey P. Cunard
    ,
    Andrew J. Gershon
    ,
    Stuart Hammer
    ,
    Jin-Hyuk Jang
    ,
    Kim T. Le
    ,
    Sheena Paul
    ,
    Tricia Bozyk Sherno
    ,
    Jacob W. Stahl
    ,
    Jennifer Wheater
    ,
    John Young
    ,
    Adam Aukland-Peck
    ,
    Dominic Blaxill
    ,
    Charles Cartiglia
    ,
    Robert T. Dura
    ,
    Paul Eastham
    ,
    Jay E. Evans
    ,
    Norma Angelica Lopez Campos
    ,
    David J. Hotelling
    ,
    Samuel D. Krawiecz
    ,
    Wen-Wei Lai
    ,
    Robert Maddox
    ,
    Sergio Torres
    ,
    Malina Welman
  • The Supreme Court TransUnion Case: Part 2—What It Means for Efforts to Defeat Class Certification?
    9 July 2021
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Jim Pastore
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Benjamin Leb
  • Law360: TCPA Litigation And Compliance After Facebook Ruling
    13 April 2021
    Law360
    Maura Kathleen Monaghan
    ,
    Jacob W. Stahl
    ,
    Harold W. Williford
    ,
    Adam Aukland-Peck
  • The Supreme Court Rules for Facebook: What It Means for TCPA Compliance and Class Certification Defense
    7 April 2021
    Courtney M. Dankworth
    ,
    Maura Kathleen Monaghan
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Harold W. Williford
  • The Eleventh Circuit Precludes “Administrative Feasibility” but Provides a Path Forward for Defendants Opposing Class Certification in Consumer Class Actions
    9 February 2021
    Maura Kathleen Monaghan
    ,
    Kristin D. Kiehn
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Harold W. Williford
    ,
    Kelly Rose O'Reilly

Upcoming Events

Recent Events